
Accuitive Medical Ventures
Description
Accuitive Medical Ventures is a Georgia-based venture capital firm established in 2001, specializing in early-stage medical device and technology companies. The firm manages approximately $250 million across two funds, with its first fund closing at $100 million in 2001 and its second at $150 million in 2006. Accuitive's investment thesis has historically centered on identifying innovative technologies with the potential to significantly impact patient care and generate substantial returns.
Over its active investment period, Accuitive Medical Ventures built a portfolio of promising companies, many of which achieved successful exits. Notable examples include Acclarent, a medical device company acquired by Johnson & Johnson for approximately $785 million, and CardioMEMS, which was acquired by St. Jude Medical for $450 million. Another significant exit was Spinal Kinetics, acquired by Orthofix for $45 million. These acquisitions underscore Accuitive's ability to identify and nurture companies that become attractive targets for larger medical corporations.
While Accuitive Medical Ventures has a strong track record of successful investments and exits, its last reported fund close was in 2006, and its most recent investment activity appears to date back to around 2012-2013. This suggests that the firm is likely no longer actively making new first-time investments but is instead focused on managing its existing portfolio, providing follow-on capital where necessary, and pursuing further liquidity events for its remaining holdings.
Investor Profile
Accuitive Medical Ventures has backed more than 53 startups, with 0 new investments in the last 12 months alone. The firm has led 6 rounds, about 11% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series D rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Medical Device, Biotechnology.
Stage Focus
- Series B (21%)
- Series C (21%)
- Series D (17%)
- Series Unknown (17%)
- Series A (8%)
- Series E (6%)
- Series G (4%)
- Debt Financing (4%)
- Private Equity (2%)
- Post Ipo Equity (2%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Medical Device
- Biotechnology
- Medical
- Pharmaceutical
- Therapeutics
- Manufacturing
- Health Diagnostics
- Diabetes
- Information Technology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.